Dewey Jones, MD
Orthopaedic Surgery · Hoover, ALNPI 1053330316
Payments from drug & device makers
Across 162 payments — averaging $103.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Prime Surgical, LLC$4K
- Amgen$879
- EMD Serono, Inc.$322
- Bioventus LLC$193
- Johnson & Johnson$173
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$9,00054%
- Travel & lodging$2,39014%
- Food & beverage$3,35820%
- Education$1,95712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 6 | $9,964 |
| Prime Surgical, LLC | 9 | $3,872 |
| Amgen(2 entities) | 76 | $879 |
| EMD Serono, Inc. | 11 | $322 |
| Bioventus LLC | 4 | $193 |
| Johnson & Johnson(2 entities) | 7 | $173 |
| Pacira Therapeutics, Inc. | 9 | $150 |
| Sanara Medtech Inc. | 1 | $146 |
| Pacira Pharmaceuticals Incorporated | 6 | $124 |
| Globus Medical | 1 | $104 |
| Acumed LLC | 1 | $103 |
| Stryker | 3 | $101 |
| Kerecis Limited | 3 | $91 |
| Smith+Nephew | 4 | $78 |
| Avanos Medical | 4 | $75 |
| Boston Scientific | 3 | $59 |
| Solventum Corporation | 2 | $42 |
| Atland Pharmaceuticals, LLC | 1 | $42 |
| Baudax Bio Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Conmed Corporation | 1 | $21 |
| Heraeus Medical, LLC. | 1 | $20 |
| Vertex | 1 | $19 |
| Davol Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Advanced Oxygen Therapy Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Convatec Inc. | 1 | $14 |
| ERMI LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACUMED$308
- CellerateRx$146
- XCELL$128
- ALIF$104
How this compares
$16,706 in reported general payments places this provider in the 75th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 206 | $1,380 |
| Celecoxib | 41 | $677 |
| Ondansetron Hcl | 90 | $664 |
| Meloxicam | 56 | $234 |
| Methocarbamol | 43 | $191 |
| Tramadol Hcl | 90 | $187 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $182 |
| Methylprednisolone | 18 | $169 |
| Amoxicillin | 64 | $149 |
| Ibuprofen | 12 | $77 |
| Naproxen | 16 | $66 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hoover
- Christopher HeckHoover$166K
- Kenneth JaffeHoover$96K
- Jeffrey DugasBirmingham$11.7M
- Benton EmblomBirmingham$3.1M
- James SmithGadsden$2.7M
- Herrick SiegelBirmingham$1.3M
- Paul CanaleDaphne$609K
- Kenneth MooreBirmingham$342K
- Jeffrey DavisBirmingham$293K
- Joseph SherrillBirmingham$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.